14-fold increased prevalence of rare glucokinase gene variant carriers in unselected Danish patients with newly diagnosed type 2 diabetes-Reference-Cited by-同舟云学术

14-fold increased prevalence of rare glucokinase gene variant carriers in unselected Danish patients with newly diagnosed type 2 diabetes

Published:2022-12 Issue: Volume:194 Page:110159
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Gjesing Anette P.,Engelbrechtsen Line,Cathrine B. Thuesen Anne,Have Christian T.,Hollensted Mette,Grarup Niels,Linneberg Allan,Steen Nielsen Jens,Christensen Lotte B.,Thomsen Reimar W.,Johansson Kristoffer E.,Cagiada Matteo,Gersing Sarah,Hartmann-Petersen Rasmus,Lindorff-Larsen Kresten,Vaag Allan,Sørensen Henrik T.,Brandslund Ivan,Beck-Nielsen Henning,Pedersen Oluf,Rungby Jørgen,Hansen Torben

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference35 articles.

1. Definition, epidemiology and classification of diabetes in children and adolescents;Craig;Pediatr Diabetes,2009

2. Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1;Johansen;The Journal of clinical endocrinology and metabolism,2005

3. Learning from molecular genetics: novel insights arising from the definition of genes for monogenic and type 2 diabetes;McCarthy;Diabetes,2008

4. Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics;Matschinsky;Diabetes,2002

5. Glucokinase and molecular aspects of liver glycogen metabolism;Agius;Biochem J,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision treatment of beta-cell monogenic diabetes: a systematic review;Communications Medicine;2024-07-18

2. Clinical screening for GCK-MODY in 2,989 patients from the Brazilian Monogenic Diabetes Study Group (BRASMOD) and the Brazilian Type 1 Diabetes Study Group (BrazDiab1SG);Archives of Endocrinology and Metabolism;2024

3. Patients with Type 2 Diabetes and aGCKvariant are still at risk for T2D-related secondary complications;2023-12-19

4. Identification of pathogenic GCK variants in patients with common type 2 diabetes can lead to discontinuation of pharmacological treatment;Molecular Genetics and Metabolism Reports;2023-06

5. Systematic Review of Monogenic Diabetes Prognostics;2023-05-21